OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 02:25:30 2024-07-02 pm EDT | ||
| 1.26 EUR | -0.79% |
|
| Current month | +5.88% | ||
| 1 month | -23.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 1.26 | -0.79% |
| 24-07-01 | 1.27 | +6.72% |
| 24-06-28 | 1.19 | -13.14% |
| 24-06-27 | 1.37 | +0.74% |
| 24-06-26 | 1.36 | -2.86% |
Real-time BOERSE MUENCHEN
Last update July 02, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ4F7P |
| ISIN | DE000GQ4F7P1 |
| Date issued | 2023-09-05 |
| Strike | 124.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.16 € |
|---|---|
| Lowest since issue | 0.377 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
136.6
USD
Average target price
147
USD
Spread / Average Target
+7.58%
- Stock Market
- Certificates
- Certificat
